The magic drug can halve the risk of cancer death

A miracle drug that can reduce the risk of death from heart attack and cancer is considered to be the biggest breakthrough in medicine since taking statins.

The new drug is able to reduce the risk of heart attack by a quarter, halving the risk of dying from cancer and protecting the body against gout and arthritis.

Scientists have found that reducing inflammation in the body can counteract a variety of cancer-causing causes with a "really impressive effect" . Accordingly, canakinumab , which is given every 3 months, reduces the risk of heart attacks by ¼, while the statin reduces risk by only about 15%. Experts are calling for emergency testing to test the impact of the drug on this deadly disease.

This method promises to "open a new era" in the treatment of cardiovascular patients - (Photo: Telegraph)

Harvard Medical School Professor Paul Ridker presented these findings at the European Heart Association Conference in Barcelona, ​​a study report published in the New England Journal of Medicine.

This landmark study was conducted with 10,000 heart attack patients receiving canakinumab, an anti-inflammatory drug. After four years, people who received high-dose medication reduced their risk of death by 24% and heart attack by 36%. The risk of death from cancer dropped to 51%, gout decreased by 56% and osteoarthritis decreased by 33%.

Harvard scientists say the method promises to "open a new era" in treatment.

Dr. Ridker, Women's Hospital in Boston, said: "These findings end up over two decades of research, stemming from an important observation: Half of all heart attacks occur in people who do not have "High cholesterol. For the first time, we have been able to clearly demonstrate that reducing inflammation also helps reduce cardiovascular risks."

Inflammation is one of the body's natural reactions to infection or injury. But it also plays a major role in causing heart attacks and stroke. Experts say high levels of cancer-related inflammation, rheumatoid arthritis, osteoarthritis and gout - all decrease in treated patients.

People treated with this new drug had a 24% reduction in heart attacks and 17% of angina attacks, a 51% reduction in cancer deaths - (Photo: Telegraph).

New treatments - working by blocking part of the immune system called interleukin-1 - currently cost about £ 40,000 a year compared to just 20 pounds if using statins. But experts say the cost of treatment will be greatly reduced if this method is widely applied. On the other hand, the cost of buying drugs is high but still cheaper than the amount of patients paying to perform other forms of surgery.

Leading British scientists have praised these findings as "interesting" and extremely important. The team also said they would apply for a license for the drug to treat heart disease.

Statin (or HMG-CoA reductase inhibitor) is a class of pharmaceuticals used to reduce cholesterol by inhibiting the enzyme HMG-CoA reductase, a key component in liver cholesterol production, where about 70% of total cholesterol in the body. High cholesterol levels have been shown to correlate with cardiovascular disease.